Regenerative Medical Technology Group Inc.
RMTG
$0.09
$0.00-4.44%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.41M | 6.38M | 5.10M | 5.04M | 4.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.41M | 6.38M | 5.10M | 5.04M | 4.84M |
| Cost of Revenue | 3.79M | 2.74M | 2.29M | 2.03M | 1.59M |
| Gross Profit | 5.63M | 3.63M | 2.81M | 3.01M | 3.26M |
| SG&A Expenses | 5.13M | 3.98M | 3.32M | 2.97M | 2.76M |
| Depreciation & Amortization | 362.90K | 326.90K | 281.00K | 154.90K | 167.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.28M | 7.05M | 5.89M | 5.15M | 4.51M |
| Operating Income | 130.20K | -671.10K | -787.40K | -113.10K | 330.80K |
| Income Before Tax | -9.53M | -8.07M | -7.95M | -7.20M | -3.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.53 | -8.07 | -7.95 | -7.20 | -3.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.53M | -8.07M | -7.95M | -7.20M | -3.73M |
| EBIT | 130.20K | -671.10K | -787.40K | -113.10K | 330.80K |
| EBITDA | 493.20K | -344.10K | -506.30K | 124.70K | 581.30K |
| EPS Basic | -0.74 | -0.64 | -0.63 | -0.57 | -0.30 |
| Normalized Basic EPS | -0.44 | -0.38 | -0.37 | -0.34 | -0.19 |
| EPS Diluted | -0.74 | -0.64 | -0.63 | -0.57 | -0.30 |
| Normalized Diluted EPS | -0.44 | -0.38 | -0.37 | -0.34 | -0.19 |
| Average Basic Shares Outstanding | 51.82M | 51.14M | 50.54M | 50.16M | 50.16M |
| Average Diluted Shares Outstanding | 51.82M | 51.14M | 50.54M | 50.16M | 50.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |